CD4 and lung adenocarcinoma: Similarly to CD4 cells, systemic CD8 T cells specific for lung adenocarcinoma antigens were quantified in G1 and G2 patients and found to be comparable (Fig EV5C) and distributed within non‐THD and THD subsets (Fig EV5D).